Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Seres Therapeutics patents

Patents where

Current Assignee

Name

Seres Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10064900 Methods of populating a gastrointestinal tract	Patent 10064900 was granted and assigned to Seres Therapeutics on September, 2018 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10064900	September 4, 2018
‌ US Patent 9446080 Compositions and methods	Patent 9446080 was granted and assigned to Seres Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	9446080	September 20, 2016
‌ US Patent 11185562 Compositions and methods for inhibition of pathogenic bacterial growth	Patent 11185562 was granted and assigned to Seres Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11185562	November 30, 2021
‌ US Patent 10064901 Compositions and methods	Patent 10064901 was granted and assigned to Seres Therapeutics on September, 2018 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10064901	September 4, 2018
‌ US Patent 10973861 Compositions and methods	Patent 10973861 was granted and assigned to Seres Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10973861	April 13, 2021
‌ US Patent 10076546 Network-based microbial compositions and methods	Patent 10076546 was granted and assigned to Seres Therapeutics on September, 2018 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10076546	September 18, 2018
‌ US Patent 10967011 Compositions and methods	Patent 10967011 was granted and assigned to Seres Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10967011	April 6, 2021
‌ US Patent 10258655 Synergistic bacterial compositions and methods of production and use thereof	Patent 10258655 was granted and assigned to Seres Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10258655	April 16, 2019
‌ US Patent 11464812 Synergistic bacterial compositions and methods of production and use thereof	Patent 11464812 was granted and assigned to Seres Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11464812	October 11, 2022
‌ US Patent 9533014 Synergistic bacterial compositions and methods of production and use thereof	Patent 9533014 was granted and assigned to Seres Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Seres Health	Seres Therapeutics	United States Patent and Trademark Office	9533014	January 3, 2017
‌ US Patent 10881696 Network-based microbial compositions and methods	Patent 10881696 was granted and assigned to Seres Therapeutics on January, 2021 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10881696	January 5, 2021
‌ US Patent 9956282 Bacterial compositions and methods of use thereof for treatment of immune system disorders	Patent 9956282 was granted and assigned to Seres Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	9956282	May 1, 2018
‌ US Patent 9180147 Compositions and methods	Patent 9180147 was granted and assigned to Seres Therapeutics on November, 2015 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	9180147	November 10, 2015
‌ US Patent 11458174 Synergistic bacterial compositions and methods of production and use thereof		Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11458174	October 4, 2022
‌ US Patent 11458173 Synergistic bacterial compositions and methods of production and use thereof	Patent 11458173 was granted and assigned to Seres Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11458173	October 4, 2022
‌ US Patent 9585921 Compositions and methods	Patent 9585921 was granted and assigned to Seres Therapeutics on March, 2017 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	9585921	March 7, 2017
‌ US Patent 11266699 Synergistic bacterial compositions and methods of production and use thereof	Patent 11266699 was granted and assigned to Seres Therapeutics on March, 2022 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11266699	March 8, 2022
‌ US Patent 9855303 Compositions and methods	Patent 9855303 was granted and assigned to Seres Therapeutics on January, 2018 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	9855303	January 2, 2018
‌ US Patent 10864235 Synergistic bacterial compositions and methods of production and use thereof	Patent 10864235 was granted and assigned to Seres Therapeutics on December, 2020 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	10864235	December 15, 2020
‌ US Patent 11389490 Synergistic bacterial compositions and methods of production and use thereof		Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11389490	July 19, 2022
‌ US Patent 11666612 Network-based microbial compositions and methods		Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11666612	June 6, 2023
‌ US Patent 11918612 Synergistic bacterial compositions and methods of production and use thereof	Patent 11918612 was granted and assigned to Seres Therapeutics on March, 2024 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11918612	March 5, 2024
‌ US Patent 11701394 Compositions and methods for treating cholestatic disease		Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	11701394	July 18, 2023
‌ US Patent 12083151 Synergistic bacterial compositions and methods of production and use thereof	Patent 12083151 was granted and assigned to Seres Therapeutics on September, 2024 by the United States Patent and Trademark Office.	Seres Therapeutics	Seres Therapeutics	United States Patent and Trademark Office	12083151	September 10, 2024

24 results

0 selected

24 results

0 selected